WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006081445) TREATMENT OF METASTASIZED TUMORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/081445    International Application No.:    PCT/US2006/002979
Publication Date: 03.08.2006 International Filing Date: 27.01.2006
IPC:
A61K 31/497 (2006.01), C11D 3/00 (2006.01)
Applicants: NOVARTIS VACCINES AND DIAGNOSTICS INC. [US/US]; Intellectual Property-R440, P.O. Box 8097, Emeryville, California 94662-8097 (US) (For All Designated States Except US).
LOPES DE MENEZES, Daniel [PT/US]; (US) (For US Only).
HEISE, Carla [US/US]; (US) (For US Only).
XIN, Xiaohua [CN/US]; (US) (For US Only)
Inventors: LOPES DE MENEZES, Daniel; (US).
HEISE, Carla; (US).
XIN, Xiaohua; (US)
Agent: MEARA, Joseph P.; Foley & Lardner LLP, 150 East Gilman Street, P.O. Box 1497, Madison, Wisconsin 53701-1497 (US)
Priority Data:
60/647,568 27.01.2005 US
60/669,245 06.04.2005 US
60/722,053 29.09.2005 US
Title (EN) TREATMENT OF METASTASIZED TUMORS
(FR) TRAITEMENT DE TUMEURS METASTATIQUES
Abstract: front page image
(EN)Methods of treating metastatic cancer such as metastasized tumors include administering a compound of Structure I, a tautomer of the compound, a pharmaceutically acceptable salt of the compound, a pharmaceutically acceptable salt or the tautomer, or a mixture thereof to a subject. The compound, tautomer, salt of the compound, salt of the tautomer, or mixture thereof may be used to prepare medicaments for treating metastatic cancer. The variable A has the values defined herein.
(FR)L'invention concerne les procédés de traitement d'un cancer métastatique tel que des tumeurs métastatiques qui consistent à administrer un composé de structure (I), un tautomère ce composé, un sel acceptable sur le plan pharmaceutique de ce composé, un sel acceptable sur le plan pharmaceutique ou le tautomère, ou un mélange de ceux-ci à un patient. Le composé, le tautomère, le sel de composé, le sel de tautomère ou un mélange de ceux-ci peuvent être utilisés afin de préparer des médicaments destinés à traiter un cancer métastatique. La variable A possède des valeurs définies dans cette invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)